Refractory warts: topical or intralesional cidofovir options

Published Date: 02 Mar 2023

New research suggests that cidofovir may be a helpful option for tender joints or joints.

Read Full News

Latest News

Can Children Stop Psoriasis Treatment After Remission?

Treatment discontinuation appears to be feasible in children with moderate-to-severe psoriasis for at least 6 months after treatment discontinuation during remission, a study finds.

Panel Provides Consensus for Standardizing CSCC Imaging

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

Unapproved Peptides Common in Australia Despite Crackdown

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

FPT Plus Pulsed Dye Laser Effective for Port-Wine Birthmarks

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Skin Cancer: 5 Practical Tips for Earlier Detection

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

Dermatology AI Is Here. Now Comes the Hard Part

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Todays Updates

Race, Geography Linked to Gaps in Prostate Cancer Care

A US government study finds racial disparities in care and a complicated relationship between distance to major cancer centers and patients’ treatment and outcomes.

Latest News

Treatment discontinuation appears to be feasible in children with moderate-to-severe psoriasis for at least 6 months after treatment discontinuation during remission, a study finds.

Guidelines are now available to optimize imaging for the evaluation and surveillance of cutaneous squamous cell carcinoma, a document that is expected to inform future guidelines.

Online sales of unapproved peptides are booming, and patients injecting these drugs are increasingly presenting to EDs with severe or life-threatening side effects.

Sequential 1550-nm fractional focal point technology followed by pulsed dye laser is safe and effective for reducing resistant port-wine birthmarks, a new study suggests.

Five practical strategies can help clinicians recognize suspicious skin lesions early and support timely biopsy, referral, and diagnosis of skin cancer.

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

News All Time

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Detecting Hidradenitis Suppurativa: Bringing the Patient's Voice to the Forefront

Advancing Chronic Spontaneous Urticaria Care in Community-Based Dermatology Practices: Providing Timely Diagnosis, Monitoring Treatment Response, and Evaluating Novel Therapeutic Options

Advancing Chronic Spontaneous Urticaria Care in Community-Based Dermatology Practices: Providing Timely Diagnosis, Monitoring Treatment Response, and Evaluating Novel Therapeutic Options

Personalizing Chronic Spontaneous Urticaria Care in Community-Based Allergy/Immunology Practices: Examining Pathogenesis, Endotypes, and Therapeutic Options

Personalizing Chronic Spontaneous Urticaria Care in Community-Based Allergy/Immunology Practices: Examining Pathogenesis, Endotypes, and Therapeutic Options

New Name for PCOS More Accurately Reflects Condition

The condition is now called polyendocrine metabolic ovarian syndrome

Make the Diagnosis: This Is a Curious Cluster. Can You Diagnose It?

A 21-year-old woman visited her doctor for multiple moles on her chest that first developed in her early teenage years and progressively increased in size and quantity over the years. Can you diagnose the patient?

GLP-1 Drug Makes Its Case for Treating Plaque Psoriasis

Adding tirzepatide helped patients shed pounds, improved complete skin clearance rates

Pediatric Hereditary Angioedema Treatment Options Growing

From scant data, the armamentarium is expanding, with an increasing evidence base

The Truth About 'Life-Changing Sunburns,' According to a Dermatologist

Can one severe sunburn have serious consequences?

Volixibat Soothed the Itch in Primary Sclerosing Cholangitis

IBATS inhibitor led to improvement in cholestatic pruritus

PCSK9 Inhibitors Linked to Better Survival in Some Cancer Patients on Immunotherapy

Prospective clinical trials needed to validate the findings

Melanoma Vaccine Halves Risk of Recurrence, Metastasis Over 5 Years

Adjuvant approach will need confirmation from ongoing phase III trial, says expert

Trump's Hair-Loss Drug; Bringing Americans With Ebola to U.S.; Widespread ACA Fraud?

Health news and commentary gathered by MedPage Today staff

Novel Lupus Drugs Continue to Shine in Extended Early Data

For one of the two, the benefits continue long after treatment stops

How Much Prednisone Is Too Much in Treating Rheum Effects From Cancer Therapies?

French study posits an answer

What Is Causing This Woman's Swollen Chin?

A long and challenging diagnostic path with twists and turns

FDA OKs First New Sunscreen Ingredient in a Quarter Century

Bemotrizinol blocks UVA and UVB and has been available in Europe since 1999

Recommended News For You

In Acute Myeloid Leukemia Diagnosed Recently, FLT3 Inhibitor Is Very Effective.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy

Study finds that AI is better at forecasting the risk of developing cancer.

Rural residents continue to have higher odds of skin cancer, study finds

Two medications might work better for breast cancers that are resistant to one.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

Measurable Residual Disease Predicts Real-World AML Relapse

Recommended Articles For You

Understanding Iron Saturation Levels in Your Blood  

Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome 

Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery 

Preventing Functional Iron Deficiency in High-Risk Populations 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Combo of Approved Agents Active in High-Risk Large B-Cell Lymphoma

2.

Elder Abuse: Red Flags to Look Out For While Receiving Care.

3.

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

4.

Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma

5.

Scientists pioneer noninvasive 3D imaging to enhance skin cancer management

1.

Essential Applications in Oncology in Daily Practice

2.

Decoding Granular Cell Tumor: What You Need to Know

3.

Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts

4.

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist 

5.

Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot